Abbott Laboratories said its board approved an amendment to its bylaws to reduce the size of the board of directors to 12 members from 13, effective April 24, 2026. The change updates the first sentence of Article III, Section 2 of the company’s bylaws.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbott Laboratories published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-018167), on February 20, 2026, and is solely responsible for the information contained therein.